GlassScriptPhysician profile
Alan B Newman
NPI 1518966951
$2,514.91
in general payments reported to CMS, 2019-2025
32 companies · $467 in 2025
The $467 reported for 2025 was more than what 79% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $241 · 2020: $62.22 · 2021: $294 · 2022: $462 · 2023: $712 · 2024: $277 · 2025: $467.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,456.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,455.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $329.57 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $325.59 | 2023-2025 | Myfembree |
| Exeltis, USA INC. | $219.74 | 2021-2025 | Slynd |
| Astellas Pharma US INC | $190.52 | 2023-2025 | Veozah, Myrbetriq |
| Pfizer INC. | $170.71 | 2021-2025 | |
| Myovant Sciences INC. | $148.01 | 2021-2022 | |
| Amgen INC. | $125.18 | 2019-2024 | Prolia, Evenity |
| Hologic Sales and Service, LLC | $109.78 | 2021-2024 | Acessa Provu System, Novasure |
| Mayne Pharma Commercial LLC | $89.76 | 2021-2023 | |
| Myriad Women'S Health, INC. | $80.57 | 2023 | Myrisk |
| Coopersurgical, INC. | $79.58 | 2020-2025 | Paragard T 380a |
| Bayer Healthcare Pharmaceuticals INC. | $66.44 | 2021-2023 | |
| Aspira Women'S Health INC | $64.11 | 2022 | |
| Distalmotion US | $60.81 | 2025 | Dexter L6 Robot |
| Amag Pharmaceuticals, INC. | $41.83 | 2019-2022 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gynesonics, INC. | $39.05 | 2023-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Organon LLC | $38.70 | 2022-2025 | Nexplanon |
| Sage Therapeutics, LLC | $37.32 | 2025 | Zurzuvae |
| Exact Sciences Corporation | $34.62 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Mylan Pharmaceuticals INC. | $30.92 | 2019-2022 | |
| Agile Therapeutics, INC. | $29.41 | 2022-2023 | Twirla |
| Allergan, INC. | $26.46 | 2019 | |
| Avion Pharmaceuticals | $24.93 | 2019 | |
| Millicent US INC | $20.47 | 2025 | Femlyv |
| Daiichi Sankyo INC. | $20.00 | 2022 | |
| Mimedx Group, INC. | $19.91 | 2024 | |
| Channel Medsystems, INC. | $17.21 | 2023 | |
| Supernus Pharmaceuticals, INC. | $16.74 | 2025 | Qelbree |
| Covidien LP | $16.40 | 2019 | |
| Therapeuticsmd, INC. | $15.51 | 2022 | |
| Meditrina | $13.79 | 2023 | |
| Merck Sharp & Dohme LLC | $11.27 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Newman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.